Wyoming Liberty Group
Boyd Wiggam and Glenn Woods discuss Special Districts, local property taxes and special district reform bills pending before the Wyoming Legislature.
Boyd Wiggam and Glenn Woods discuss economic liberty and the Transportation Network Companies bill before the Wyoming legislature that would allow internet-based, ride sharing companies like Uber and Lyft to operate in Wyoming.
We have discussed how Wyoming’s alcohol regulatory system limits new small business opportunities without effectively deterring destructive behavior attributable to alcohol. The state rankings of alcohol abuse measured by DUI arrests per capita and binge drinking rate highlight some similar rural states that have combined market-friendly liquor licensing with lower levels of alcohol abuse.
West Virginia and Utah are the only two among the ten most responsible drinking states in both binge-drinking and DUI measures. Wyoming isn’t top ten in either. Unfortunately, Wyoming tops the chart in one category – drunk driving arrests per share of population. Therefore, market-oriented liquor license regulations in West Virginia or Utah do not necessarily lead to more irresponsible or dangerous behavior than exist under Wyoming’s current licensing regime.
Wyoming’s disturbing rate of alcohol-related calamity is no secret. Two ways to measure alcohol abuse among adults are to look at DUI arrests per capita and binge drinking rate. These measures show Wyoming leads the nation in DUI arrests per capita and is in the CDC’s second tier of states (out of three tiers) for binge drinking prevalence. Based on these data points, Wyoming’s system for regulating the alcohol market appears to be ineffective in deterring destructive behavior attributable to alcohol.
Boyd Wiggam discusses how the Legislature's Corporations Committee is addressing several local government regulatory trends that can stand in the way of new, private business development in Wyoming with Gary Freeman on KGAB.
Every 8 weeks, Paula Bennet visits a primary care clinic to receive Remicaid infusions to treat her Crohn’s disease. Normally, an appointment like this would cost $30 in copays. But in Paula’s case, her health plan pays her.